...
首页> 外文期刊>Journal of radiological science. >Acute Adverse Reactions of Three Intravenous lodinated Contrast Media in Computed Tomography under Routine Clinical Monitoring: lothalamate meglumine, lopromide and lohexol
【24h】

Acute Adverse Reactions of Three Intravenous lodinated Contrast Media in Computed Tomography under Routine Clinical Monitoring: lothalamate meglumine, lopromide and lohexol

机译:常规临床监测下计算机断层扫描中三种静脉输液造影剂的急性不良反应:洛他胺葡甲胺,洛普罗米特和洛海醇

获取原文
获取原文并翻译 | 示例
           

摘要

Nonionic iodinated contrast media (NICM) is generally considered to have a much lower incidence of acute adverse drug reactions (aADRs) than ionic iodinated contrast media (IICM). Several studies have compared aADRs of IICM to NICM but few compared between different NICMs. There are few large local studies of adverse reactions to iodinated contrast media (ICM) in Taiwan. We undertook a retrospective study to compare the aADRs between different ICM in computed tomography (CT) under routine clinical monitoring.All consecutive patients who received intravenous contrast-enhanced CT scans using lothalamate meglumine, lopromide, or lohexol from May 2004 to February 2006 were enrolled. In total 32499 enrolled patients received either lothalamate meglumine (7520, 23.14%), lopromide (9830, 30.25%), or lohexol (15149, 46.61%). Two categories of injection rate were classified: rapid (>2 mL/sec) and slow (manual injection). Acute ADRs were classified by systemic symptoms. The statistical methods used were Fisher's exact test and Chi-squared test.
机译:通常认为非离子碘化造影剂(NICM)的急性不良药物反应(aADR)的发生率比离子碘化造影剂(IICM)低得多。几项研究已将IICM的aADR与NICM进行了比较,但在不同NICM之间进行了比较。在台湾,关于碘化造影剂(ICM)不良反应的大型本地研究很少。我们进行了一项回顾性研究,以比较在常规临床监测下计算机X线断层扫描(CT)中不同ICM之间的aADR。从2004年5月至2006年2月,所有连续接受使用洛他米特葡甲胺,洛普罗米特或洛hexol进行静脉对比增强CT扫描的患者入组。 。在总共32499名入组患者中,接受了洛他米特葡甲胺(7520,23.14%),洛普罗米德(9830,30.25%)或洛己醇(15149,46.61%)。进样速率分为两类:快速(> 2 mL / sec)和慢速(手动进样)。急性ADR按全身症状分类。使用的统计方法是Fisher精确检验和卡方检验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号